Home / Tourism / Tourists vaccinated with Sinopharm and AstraZeneca will be able to travel to Europe

Tourists vaccinated with Sinopharm and AstraZeneca will be able to travel to Europe

Europe has chosen to open its borders to tourists, provided they are vaccinated. Four vaccines were selected, in addition to the Chinese Sinopharm vaccine.

Non-European tourists will be able to travel to the old continent this summer, provided they have received the necessary doses for at least four days. They must have received one of the four European vaccines, namely Moderna, Pfizer-BioNTech, Astrazeneca, or Johnson & Johnson.

In addition, States will be able to accept tourists who have received one of the sera with emergency WHO approval, such as the Chinese Sinopharm vaccine.

This decision of the 27 can however be readjusted locally and each country could require PCR tests or quarantine periods.

For the moment, the list of authorized countries only includes Australia, New Zealand, Rwanda, Singapore, South Korea, Thailand and Israel, but this list could significantly grow as a result.

Indeed, Morocco, where the health situation seems to be under control, could join this list, given that the two vaccines administered as part of the vaccination campaign are the European AstraZeneca and the Chinese Sinopharm.

To date, the number of people who have received the first dose of the vaccine in Morocco has reached 7029682, while those who have been fully vaccinated (1st and 2nd doses) number 4673903.

In addition, after a year of suspension caused by the coronavirus pandemic, Spain has again reopened the possibility for Moroccans to obtain Schengen visas.

Spain, however, imposes conditions that must be met for visa applicants. The latter must have obtained, within the last two years, a Schengen visa of at least six months or two Schengen visas of three months.

Check Also

Resumption of flights to and from Morocco from June 15, 2021

The Moroccan authorities have decided to resume flights to and from the Kingdom as of …

Leave a Reply